Eidogen-Sertanty And Specs Release Kinase-Targeted Compound Library 
10/19/2005 5:09:12 PM

SAN DIEGO--(BUSINESS WIRE)--Sept. 6, 2005--Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, and Specs, a leading supplier of screening compounds and research chemicals, today announced the launch of a small molecule library focused toward inhibitors of several protein kinase families. This Kinase-Targeted Library represents the culmination of a co-marketing and collaborative service agreement between Eidogen-Sertanty and Specs.